巨仁堂品牌怎么样 申请店铺

我要投票 巨仁堂在连锁药店行业中的票数:236 更新时间:2025-04-20
巨仁堂是哪个国家的品牌?吉林巨仁堂药业股份有限公司,座落在药材宝库长白山南麓、浑江之畔、风景秀丽的通化市。公司始建于1975年,厂区占地面积4.5万平方米,建筑面积20000平方米,公司现有职工278人,营销人员1500多人

外推网助力巨仁堂品牌出海!通过在本页面挂载巨仁堂品牌的产品链接和联系邮箱,可以提高巨仁堂产品曝光!跨境电商爆单神器,目前只要100元/年哦~

巨仁堂怎么样

吉林巨仁堂药业股份有限公司,座落在药材宝库长白山南麓、浑江之畔、风景秀丽的通化市。公司始建于1975年,厂区占地面积4.5万平方米,建筑面积20000平方米,公司现有职工278人,营销人员1500多人,营销网络遍布全国30个省,是一家集科研、生产、销售为一体的制药企业。她以技术力量强大,工艺设备先进,品种好又多,发展资金雄厚等优势,在医药舞台上发挥着越来越重要的作用。 

由于地处长白山,占有得天独厚的地理位置和资源优势,其产品采用长白山天然名贵药材精制而成,产品质量好,疗效高,深得广大患者信赖。公司总经理董起毓带领公司全体员工艰苦创业、诚信经营、以人为本、科技创新、开拓发展,通过创新企业管理机制、经营机制,开拓市场,开发新产品,大胆聘用制药人才,与科研部门合作,从而带出了一支有凝聚力的高素质企业队伍。  

2002年,企业筹集资金14500万元,进行GMP改造,2004年1月顺利通过达标验收,建成颗粒剂、丸剂、胶囊剂三个剂型的大型现代化制药企业,使企业的整体形象、生产能力大为改观,企业迈上了快速发展的轨道。在企业不断发展壮大的形势下,企业经济效益逐年提高,由于销量上升过快,2004年企业又筹集资金13500多万元,对丸剂、水蜜丸、口服液、糖浆剂进行GMP改造,2004年12月27日顺利通过国家GMP认证。两期GMP改造的成功认证,使企业的生产设施和产品质量已经达到国内领先的高科技水平。  

目前,已上市的产品有10个系列,共计38个品种,为企业的长足发展奠定了基础。 

多年来,企业利用地理资源优势,以严格的企业管理,与时俱进的工作精神,不断开拓市场,开展企业文化,来鼓舞人,激励人,凝聚人。公司生产的巨焱消牌炎立消胶囊(出口名称:CLOVERY)已获得出口资质,即已获得美国FDA认证和加拿大DIN认证。  

为确保出口产品重金属含量合格,保证出口产品的质量和数量,目前公司正在建设绿色中药材GAP生产基地,公司引进了先进的生产提取设备,建设了现代化的标准出口生产车间。绿色中药材GAP生产基地项目投产后,可年产中药材545吨,可满足本企业的需求。 

多年来,企业利用地理资源优势,以严格的企业管理,与时俱进的工作精神,不断开拓市场,增强效益。并获得了“纳税大户”、“重合同守信用企业”、“先进企业”、“重点保护单位”、“高新技术企业”等荣誉称号。巨仁堂药业正以稳健的脚步,踏上快速发展的轨道,去迎接并战胜更大的挑战。


Jilin jurentang Pharmaceutical Co., Ltd. is located in Tonghua City, which is located at the south foot of Changbai Mountain, Hunjiang River and has beautiful scenery. Founded in 1975, the company covers an area of 45000 square meters and a building area of 20000 square meters. The company has 278 employees and more than 1500 marketing personnel. Its marketing network covers 30 provinces in China. It is a pharmaceutical enterprise integrating scientific research, production and sales. She plays a more and more important role in the pharmaceutical stage with the advantages of strong technical force, advanced technology and equipment, good variety and abundant development funds. Because it is located in Changbai Mountain, it has a unique geographical location and resource advantage. Its products are refined from Changbai Mountain's natural and precious medicinal materials, with good quality and high curative effect, which are trusted by the majority of patients. Dong Qiyu, general manager of the company, led all employees of the company to work hard, operate in good faith, put people first, innovate in science and technology, develop and develop. By innovating enterprise management mechanism and operation mechanism, the company opened up market, developed new products, boldly employed pharmaceutical talents, and cooperated with scientific research departments, thus bringing out a cohesive high-quality enterprise team. In 2002, the enterprise raised 14.5 million yuan to carry out GMP transformation. In January 2004, the enterprise successfully passed the standard acceptance and built a large-scale modern pharmaceutical enterprise with three dosage forms of granules, pills and capsules, which greatly improved the overall image and production capacity of the enterprise and put it on the track of rapid development. Under the situation of continuous development and growth of the enterprise, the economic benefit of the enterprise has been improved year by year. Due to the rapid increase of sales volume, the enterprise raised more than 135 million yuan in 2004 to carry out GMP transformation of pills, honey pills, oral liquid and syrup, and successfully passed the national GMP certification on December 27, 2004. The successful certification of two phases of GMP transformation has made the production facilities and product quality of the enterprise reach the leading high-tech level in China. At present, there are 10 series of products on the market, 38 varieties in total, which lays the foundation for the rapid development of the enterprise. Over the years, enterprises have been using the advantages of geographical resources, strict enterprise management, working spirit of keeping pace with the times, constantly opening up markets, developing corporate culture, to inspire, inspire and unite people. The juyanxiao brand Yanlixiao capsule (export name: clovery) produced by the company has obtained export qualification, i.e. FDA certification in the United States and din certification in Canada. In order to ensure that the heavy metal content of export products is qualified and the quality and quantity of export products are guaranteed, the company is currently building a gap production base for green Chinese herbal medicines. The company has introduced advanced production extraction equipment and built a modern standard export production workshop. After the production base project of green Chinese herbal medicine GAP is put into production, the annual output of Chinese herbal medicine can reach 545 tons, which can meet the needs of the enterprise. Over the years, the enterprise has made use of the advantages of geographical resources, with strict enterprise management and the working spirit of keeping pace with the times, to continuously open up the market and enhance efficiency. It has also won the honorary titles of "big tax payer", "enterprise abiding by contracts and keeping promises", "advanced enterprise", "key protection unit" and "high and new technology enterprise". Jurentang pharmaceutical industry is stepping on the track of rapid development with steady steps to meet and overcome greater challenges.

本文链接: https://brand.waitui.com/991856d39.html

千城特选小程序码

7×24h 快讯

后视摄像头图像无法显示,克莱斯勒在美召回48494辆汽车

当地时间4月19日,美国国家公路交通安全管理局(NHTSA)文件披露,由于显示模块可能无法显示后视摄像头图像,克莱斯勒将召回部分2023-2025年款阿尔法·罗密欧Tonale托纳利和道奇大黄蜂,共计48494辆。(界面)

60分钟前

一季度北京地区进出口7198.9亿元 汽车产业拉动出口增长

4月19日,据北京海关消息,今年一季度北京地区(含中央在京单位)进出口7198.9亿元。其中,出口1480.9亿元,较去年同期增长2.2%。北京外贸含“新”量进一步提升。一季度,北京地区汽车产业出口128.1亿元,同比增长56%,上拉同期地区出口增速3.2个百分点,拉动作用最强。同期,医药健康产业、绿色低碳产业分别出口31.6亿元、19亿元,同比分别增长5.8%、119.1%。

60分钟前

上海国际集团与宝山区签署战略合作框架协议 支持绿色低碳、新材料、机器人等发展

4月19日,上海国际集团与宝山区签署战略合作框架协议。双方将通过北转型基金提级扩募,重点支持宝山绿色低碳、新材料、机器人及智能制造等主导产业发展,以全链条金融服务赋能科创产业升级,并加强上市平台培育。(财联社)

60分钟前

一季度重庆外贸进出口总值1651.4亿元 同比增长4.1%

4月19日,重庆海关发布消息称,2025年一季度,重庆外贸进出口总值为1651.4亿元(人民币,下同),同比增长4.1%。据重庆海关介绍,2025年一季度,东盟是重庆第一大贸易伙伴,进出口281.4亿元,同比增长10.5%。此外,重庆对拉美、中东、非洲等新兴市场分别同比增长30.9%、9.2%、41.2%,外贸“朋友圈”持续扩大。

60分钟前

改善患者肢体运动功能 “植入式迷走神经刺激系统”临床试验启动

4月19日,国家卫生健康委组织实施“百万减残”工程重点推广项目,我国自主研发的“植入式迷走神经刺激系统”临床试验正式全国启动。该项目有望成为我国卒中后残疾防控的重要手段。迷走神经电刺激作为一种微创手术,可以辅助脑卒中患者康复治疗。数据显示,该技术能够在卒中后康复黄金期6月以后,帮助患者持续重建神经功能,明显改善患侧肢体运动功能。(财联社)

60分钟前

本页详细列出关于开心人的品牌信息,含品牌所属公司介绍,开心人所处行业的品牌地位及优势。
咨询